Share price: 112.80p

Additional Listing/TVR

10th May 2013

Cello Group plc

(the “Group” or the “Company”)

Additional listing / TVR

The Company announces that on 10 May 2013 it resolved to issue 89,122 new ordinary shares of 10p each to vendors of a business previously acquired by the Group. These shares are to be issued pursuant to the share purchase agreement in relation to Red Kite Consulting Group Limited.

Application has been made for these shares to be admitted to trading on AIM and admission is expected to occur on 16 May 2012. The Company’s issued share capital, following the admission of the 89,122 new shares, will be 82,683,959 ordinary shares of 10 pence each (“Ordinary Shares”), all with voting rights. The Company holds 237,000 Ordinary Shares in treasury at the date of this announcement. The total number of current voting rights in the Company will therefore be 82,446,959 shares.

The above figure (82,446,959 Ordinary Shares) may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FSA’s Disclosure and Transparency Rules.

 

 

For further Information please contact:

 

Cello Group plc

Mark Scott, Chief Executive                          020 7812 8460

Mark Bentley, Group Finance Director

 

Cenkos Securities plc

Bobbie Hilliam                                                  020 7397 8900

 

 

Contact Us

Dianna Hillier

Dianna.Hillier@cellohealth.com

Phone 020 7812 8468

Address

Cello Health plc

Queens House

8-9 Queen Street

London

EC4N 1SP

Registered Office

Queens House

8-9 Queen Street

London

EC4N 1SP

Company Registered

in England no.05120150